DEUTSCHE BANK AG\ - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 156 filers reported holding ASSERTIO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$13,000
-82.9%
20,092
-67.6%
0.00%
Q4 2019$76,000
-74.8%
61,919
-73.9%
0.00%
Q3 2019$302,000
-86.8%
237,227
-64.2%
0.00%
-100.0%
Q2 2019$2,284,000
-53.2%
662,722
-31.2%
0.00%
-66.7%
Q1 2019$4,880,000
+393.4%
962,958
+251.0%
0.00%
+200.0%
Q4 2018$989,000
-91.1%
274,338
-85.4%
0.00%
-66.7%
Q3 2018$11,068,0001,882,6440.00%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 127,850$164,0000.08%
PERKINS CAPITAL MANAGEMENT INC 69,600$89,0000.08%
GLOBEFLEX CAPITAL L P 213,991$274,0000.06%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,500,000$1,920,000,0000.05%
DELTEC ASSET MANAGEMENT LLC 162,700$208,0000.05%
Spark Investment Management LLC 285,588$365,0000.05%
Factorial Partners, LLC 37,000$47,360,0000.04%
HighVista Strategies LLC 43,400$56,0000.04%
OAKTREE CAPITAL MANAGEMENT LP 1,492,455$1,910,0000.04%
OXFORD ASSET MANAGEMENT LLP 1,036,375$1,327,0000.03%
View complete list of ASSERTIO THERAPEUTICS INC shareholders